LUNG | Pulmonx Corp |
Surgical & Medical Instruments & Apparatus |
Book value per $ invested | $ 0.36 |
Leverage | 43.89% |
Market Cap | $ 257.8m |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -56.7m |
Margin | -73.02% |
Pulmonx Corporation, a medical technology company, designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. The company is headquartered in Redwood City, California.